Company Filing History:
Years Active: 1995-2000
Title: Todd L Graybill: Innovator in Pharmaceutical Chemistry
Introduction
Todd L Graybill is a notable inventor based in Pottstown, PA (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 5 patents. His work primarily focuses on the development of novel compounds that have potential applications in drug discovery and therapeutic interventions.
Latest Patents
Among his latest patents, Graybill has developed a library of compounds based on aminobenzenedicarboxylic acid. This library serves as a template for synthesizing a vast array of compounds, which are analogs of the core structure. These compounds are utilized to study ligand binding by biological receptors, including enzymes and membrane channels. Notably, some compounds within this library selectively inhibit the action of trypsin-like serine proteases. Additionally, he has created methods for screening these compounds to assess their utility as pharmaceutical agents.
Another significant patent involves quinolone carboxamide calpain inhibitors. This invention includes a compound formula that features various aryl and heteroaryl groups, which can be modified to enhance their effectiveness. These innovations reflect Graybill's commitment to advancing pharmaceutical research through his inventive approaches.
Career Highlights
Throughout his career, Todd L Graybill has worked with prominent companies such as Sterling Winthrop Inc. and 3-Dimensional Pharmaceuticals, Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
Graybill has collaborated with esteemed colleagues, including Roland Ellwood Dolle and Gary J Speier. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Todd L Graybill is a distinguished inventor whose work in pharmaceutical chemistry has led to the development of valuable compounds and methodologies. His contributions continue to impact the field, showcasing the importance of innovation in drug discovery and therapeutic applications.